Dianthus Therapeutics (DNTH) Assets Average: 2018-2025
Historic Assets Average for Dianthus Therapeutics (DNTH) over the last 6 years, with Sep 2025 value amounting to $451.8 million.
- Dianthus Therapeutics' Assets Average rose 24.93% to $451.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $451.8 million, marking a year-over-year increase of 24.93%. This contributed to the annual value of $276.7 million for FY2024, which is 110.81% up from last year.
- As of Q3 2025, Dianthus Therapeutics' Assets Average stood at $451.8 million, which was up 33.92% from $337.3 million recorded in Q2 2025.
- Dianthus Therapeutics' 5-year Assets Average high stood at $451.8 million for Q3 2025, and its period low was $81.0 million during Q2 2023.
- Moreover, its 3-year median value for Assets Average was $337.3 million (2025), whereas its average is $274.4 million.
- In the last 5 years, Dianthus Therapeutics' Assets Average tumbled by 56.14% in 2023 and then spiked by 363.61% in 2024.
- Quarterly analysis of 4 years shows Dianthus Therapeutics' Assets Average stood at $123.6 million in 2022, then surged by 50.41% to $185.9 million in 2023, then spiked by 95.84% to $364.1 million in 2024, then climbed by 24.93% to $451.8 million in 2025.
- Its Assets Average stands at $451.8 million for Q3 2025, versus $337.3 million for Q2 2025 and $361.3 million for Q1 2025.